| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J0178 |
Injection, aflibercept, 1 mg |
1,010 |
643 |
$911K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
5,376 |
4,202 |
$317K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,396 |
3,668 |
$125K |
| 92134 |
|
9,465 |
7,795 |
$109K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,070 |
930 |
$49K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
558 |
480 |
$33K |
| 67228 |
|
62 |
44 |
$20K |
| J9035 |
Injection, bevacizumab, 10 mg |
507 |
409 |
$20K |
| J2777 |
Injection, faricimab-svoa, 0.1 mg |
15 |
12 |
$17K |
| J3490 |
Unclassified drugs |
268 |
203 |
$15K |
| 92235 |
|
278 |
242 |
$10K |
| 92225 |
|
64 |
38 |
$842.75 |
| G8482 |
Influenza immunization administered or previously received |
189 |
141 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
613 |
458 |
$0.00 |
| 4040F |
|
548 |
408 |
$0.00 |
| 2026F |
|
30 |
25 |
$0.00 |
| 2024F |
|
30 |
25 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
322 |
255 |
$0.00 |
| 1036F |
|
403 |
298 |
$0.00 |
| 99024 |
|
18 |
12 |
$0.00 |